Useful to consider in the context of collaborations such as @BeneluxaCoop
RT @jamesfomahony: Just spotted this published by @gorrycm and @INFO_NCPE colleagues. Understanding the differences in cost-effectiveness b…
RT @adamsncpe: Congrats Claire @INFO_NCPE on a great paper - demonstrates the similarities in the final recommendations despite the differe…
Congrats Claire @INFO_NCPE on a great paper - demonstrates the similarities in the final recommendations despite the differences which is important when considering collaborations @BeneluxaCoop
RT @ingentium_mel: Transferability of Economic Evaluations of Treatments for Advanced #melanoma #cancer. https://t.co/wIzc2OwsR3
Transferability of Economic Evaluations of Treatments for Advanced #melanoma #cancer. https://t.co/wIzc2OwsR3
RT @jamesfomahony: Just spotted this published by @gorrycm and @INFO_NCPE colleagues. Understanding the differences in cost-effectiveness b…
RT @jamesfomahony: Just spotted this published by @gorrycm and @INFO_NCPE colleagues. Understanding the differences in cost-effectiveness b…
RT @jamesfomahony: Just spotted this published by @gorrycm and @INFO_NCPE colleagues. Understanding the differences in cost-effectiveness b…
RT @jamesfomahony: Just spotted this published by @gorrycm and @INFO_NCPE colleagues. Understanding the differences in cost-effectiveness b…
RT @jamesfomahony: Just spotted this published by @gorrycm and @INFO_NCPE colleagues. Understanding the differences in cost-effectiveness b…
Just spotted this published by @gorrycm and @INFO_NCPE colleagues. Understanding the differences in cost-effectiveness between countries will be important for collaboration on pricing https://t.co/eyl3QsPlh4
#HealthEconJA Transferability of Economic Evaluations of Treatments for Advanced Melanoma https://t.co/rfxG3QJP4g